YUAN Yuhong, ZHENG Lianxue, ZHANG Dai, LI Jiuxian, YANG Shuang, DUAN Xiaojing. Effect of balanced cupping intervention in treatment of patients with primary dysmenorrhea differentiated as type of qi stagnation and blood stasis[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 126-130. DOI: 10.7619/jcmp.20240260
Citation: YUAN Yuhong, ZHENG Lianxue, ZHANG Dai, LI Jiuxian, YANG Shuang, DUAN Xiaojing. Effect of balanced cupping intervention in treatment of patients with primary dysmenorrhea differentiated as type of qi stagnation and blood stasis[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 126-130. DOI: 10.7619/jcmp.20240260

Effect of balanced cupping intervention in treatment of patients with primary dysmenorrhea differentiated as type of qi stagnation and blood stasis

More Information
  • Received Date: January 15, 2024
  • Revised Date: March 10, 2024
  • Available Online: May 31, 2024
  • Objective 

    To explore the clinical effect of balanced cupping intervention in treatment of patients with primary dysmenorrhea differentiated as type of qi stagnation and blood stasis

    Methods 

    A total of 64 patients with primary dysmenorrhea differentiated as type of qi stagnation and blood stasis in the First Affiliated Hospital of Henan University of Chinese Medicine from January 2020 to December 2021 were selected as the research objects, and they were divided into observation group and control group according to the order of consultation and patients' wishes, with 32 cases in each group. The control group received routine health guidance for dysmenorrhea, while the observation group received balanced cupping intervention on the basis of the control group. The Visual Analogue Scale (VAS) score, dysmenorrhea symptom score, serum prostaglandin E2 (PGE2), estradiol (E2), menstrual onset time, menstrual cycle, menstrual volume, and efficacy were compared between the two groups before and after treatment.

    Results 

    There were significant differences in VAS scores during the 1st, 2nd and 3rd menstruation compared with those before intervention between the two groups (P<0.05); the VAS scores of the observation group during the 1st, 2nd and 3rd menstruation were significantly lower than those of the control group (P<0.05). There were significant differences in dysmenorrhea symptom scores during the 1st, 2nd and 3rd menstruation with those before intervention between the two groups (P<0.05); the dysmenorrhea symptom score of the observation group during the 1st, 2nd and 3rd menstruation was significantly lower than those of the control group (P<0.05). The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). There were significant differences in PGE2 and E2 levels during the 1st, 2nd and 3rd menstruation with those before intervention between the two groups (P<0.05). There were significant differences in PGE2 and E2 levels between the two groups during the 1st, 2nd and 3rd menstruation (P<0.05). There were no significant differences in menstrual cycle, menstrual duration and menstrual volume between the two groups (P>0.05).

    Conclusion 

    Balanced cupping intervention has a good effect and high safety in the treatment of patients with primary dysmenorrhea differentiated as type of qi stagnation and blood stasis.

  • [1]
    李跃, 陈飞, 徐霞, 等. 平衡火罐联合督灸治疗寒凝血瘀型原发性痛经临床研究[J]. 新中医, 2020, 52(7): 117-119. https://www.cnki.com.cn/Article/CJFDTOTAL-REND202007036.htm
    [2]
    高强, 姜北, 丛慧芳. 子宫内膜异位症疼痛中医病机治法探析[J]. 辽宁中医杂志, 2021, 48(9): 90-92. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY202109024.htm
    [3]
    姜梅, 陈秋花. 灸疗过程管理策略在长蛇灸治疗寒凝血瘀型原发性痛经中的作用[J]. 中国中西医结合急救杂志, 2020, 27(2): 243-245.
    [4]
    段昆, 高霞, 耿婷, 等. 基于血清代谢组学技术探讨桂枝茯苓胶囊及其主要成分治疗原发性痛经的作用机制[J]. 中国新药杂志, 2020, 29(18): 2066-2074. doi: 10.3969/j.issn.1003-3734.2020.18.005
    [5]
    梁月凤, 黄秀敏, 温兰玲, 等. 血清脑源性神经营养因子与子宫内膜异位症临床分期及痛经的相关性[J]. 中华医学杂志, 2020, 100(10): 771-774. doi: 10.3760/cma.j.cn112137-20191205-02659
    [6]
    孙萌, 赵阳, 杨东霞. 温经汤对寒凝血瘀型原发性痛经患者血清PAF及β-内啡肽的影响[J]. 中国实验方剂学杂志, 2020, 26(2): 1-5. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202002002.htm
    [7]
    王越, 王昕. 针刺周期疗法联合血府逐瘀汤对气滞血瘀型原发性痛经患者前列腺代谢物及炎症因子影响[J]. 辽宁中医药大学学报, 2021, 23(11): 100-103. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB202111021.htm
    [8]
    李丹丹, 乔远静, 刘佳欣, 等. 综合医院住院病人对中医护理技术认知现状的调查研究[J]. 全科护理, 2022, 20(14): 1873-1876. https://www.cnki.com.cn/Article/CJFDTOTAL-JTHS202214001.htm
    [9]
    蒋新军, 陈燕, 霍依, 等. 火罐疗法对血瘀质女性经期症状及抑郁干预效果观察[J]. 护理研究, 2016, 30(5): 571-574. https://www.cnki.com.cn/Article/CJFDTOTAL-SXHZ201605018.htm
    [10]
    李杰, 江华娟, 何瑶, 等. 四物汤治疗原发性痛经的方剂配伍内涵及作用机制研究[J]. 中国中药杂志, 2020, 45(12): 2947-2953. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202012027.htm
    [11]
    刘婷, 陈波, 陈泽林, 等. 拔罐疗法标准化建设概况[J]. 中医杂志, 2021, 62(24): 2147-2152. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202124007.htm
    [12]
    刘斯祺, 王昕. 基于古书名方探讨原发性痛经中医治疗优势[J]. 辽宁中医药大学学报, 2022, 24(4): 155-159. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB202204032.htm
    [13]
    郑玮琳, 翁衡, 梁雪芳. 基于数据挖掘的古代痛经方药运用规律研究[J]. 时珍国医国药, 2017, 28(4): 1011-1015. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY201704090.htm
    [14]
    康开彪, 袁仁智. 基于关联规则和熵聚类算法的原发性痛经治疗组方用药规律探析[J]. 中医研究, 2016, 29(6): 60-63. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYJ201606030.htm
    [15]
    于文颜, 马良宵, 田园, 等. 针刺治疗原发性痛经机制的研究进展及思考[J/OL]. 针刺研究: 1-11.
    [16]
    邓春兰, 吴高鑫. 基于CiteSpace针灸治疗痛经知识图谱分析[J]. 贵州中医药大学学报, 2022, 44(2): 62-66. https://www.cnki.com.cn/Article/CJFDTOTAL-GYZX202202013.htm
    [17]
    朱丹烨. 唐代及唐代以前足太阳膀胱经文献研究[D]. 广州: 广州中医药大学, 2012.
    [18]
    李羽佳. 大椎穴刺络拔罐应用举隅[J]. 山西中医, 2013, 29(6): 36-36. https://www.cnki.com.cn/Article/CJFDTOTAL-SHIX201306022.htm
    [19]
    李凤辉, 马祖彬, 苑卉. 论肩井穴功效及临床应用[J]. 山东中医药大学学报, 2016, 40(1): 21-23. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYX201601008.htm
    [20]
    张佳佳, 王军, 白鹏, 等. 《循证针灸临床实践指南: 原发性痛经》的研制及其特点[J]. 中国针灸, 2019, 39(12): 1343-1346. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE201912027.htm
    [21]
    史菊霞, 毛慧娟, 张璐, 等. 痛经患者关元、十七椎穴伏安特性研究[J]. 上海针灸杂志, 2019, 38(1): 1-5. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZJ201901002.htm
    [22]
    CLEMENZA S, VANNUCCINI S, CAPEZZUOLI T, et al. Is primary dysmenorrhea a precursor of future endometriosis development?[J]. Gynecol Endocrinol, 2021, 37(4): 287-293.
    [23]
    BAFOR E E, KALU C H, OMORUYI O, et al. Thyme (Thymus Vulgaris[lamiaceae]) leaves inhibit contraction of the nonpregnant mouse uterus[J]. J Med Food, 2021, 24(5): 541-550.
    [24]
    IMANAKA S, SHIGETOMI H, KAWAHARA N, et al. Clinicopathological characteristics and imaging findings to identify adenomyosis-related symptoms[J]. Reprod Med Biol, 2021, 20(4): 435-443.
    [25]
    BLAGOWIDOW N. Obstetrics and gynecology in Ehlers-Danlos syndrome: a brief review and update[J]. Am J Med Genet C Semin Med Genet, 2021, 187(4): 593-598.
  • Related Articles

    [1]HU Lele, WEI Yinyu, WANG Jinyan, ZHU Kunliang, LIU Guoying. Relationships of serum angiopoietin-like protein 4 and fibroblast growth factor 23 levels with severity and prognosis of patients with diabetes nephropathy[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 56-61. DOI: 10.7619/jcmp.20240358
    [2]MA Jing, ZHENG Xisheng, LI Changli, ZHAO Congyuan, DONG Zhaogang. Correlations of serum microRNA-499A-5P, fibroblast growth factor 9 and inflammatory factor with the severity and prognosis of acute lung injury caused by sepsis[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 55-60. DOI: 10.7619/jcmp.20233049
    [3]XU Ying, XIAO Wenhuan, ZHAO Yilin, YANG Xiang, ZHONG Yunian. Relationship between cognitive function and fibroblast growth factor-2 in patients with schizophrenia and its gender difference[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 64-69. DOI: 10.7619/jcmp.20220046
    [4]HAN Bei, HAN Junling, CAO Jinghao, YU Yang, GONG Qin. Relation between intact fibroblast growth factor 23 and renal anemia in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 114-118. DOI: 10.7619/jcmp.20213812
    [5]CAI Liying, LUO Gang. Expression and significance of serum chemokine and fibroblast growth factor 21 in patients with diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 76-80. DOI: 10.7619/jcmp.20211123
    [6]DU Kaixian, HU Huihui, LI Lin, DONG Yan, GUAN Jing, SONG Chunlan, BAI Yanmin, KONG Lina, JIA Tianming. Value of fibronectin, vascular endothelial growth factor and lactate dehydrogenas levels in cerebrospinal fluid in diagnosing bacterial meningitis and viral encephalitis in children[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 26-30. DOI: 10.7619/jcmp.20210272
    [7]ZOU Xianjun, LI Hai, SUN Liang. Effect of Fufang Jingjie Fumigation Lotion on postoperativewound healing and expression of serum growth factors in patients after perianal abscess surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(9): 74-77. DOI: 10.7619/jcmp.20201801
    [8]CAI Chuanyun. Effect of modified Xiaochaihu Decoction combined with Jianwei Huayu Decoction on serum growth factor levels in patients with recurrent peptic ulcer[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 54-57. DOI: 10.7619/jcmp.202001014
    [9]ZHU Chun, HUANG Haidong, WANG Lirui, GUO Zhiyong. Influence of heme oxygenase-1 on expressions of transforming growth factor-β1 and fibronectin in peritoneal mesothelial cells of rats induced by high glucose[J]. Journal of Clinical Medicine in Practice, 2014, (1): 1-4. DOI: 10.7619/jcmp.201401001
    [10]BU Chi-wen, YANG Quan-de, LIU Jing-hong, CHEN Qian. Expressions and significance of pituitary tumor - transforming gene and basic fibroblast growth factor in breast carcinoma[J]. Journal of Clinical Medicine in Practice, 2012, (7): 18-20. DOI: 10.3969/j.issn.1672-2353.2012.07.005
  • Cited by

    Periodical cited type(17)

    1. 徐国亮. 清解补肺汤联合阿奇霉素治疗支气管扩张症的临床疗效. 福建医药杂志. 2024(03): 46-49 .
    2. 计然然,唐燕,匡宁,许翼,汤韦奇. 苏黄止咳胶囊联合福多司坦片治疗支气管扩张的效果. 西北药学杂志. 2024(06): 133-138 .
    3. 叶远航,罗成,柯佳,阚竞,宋远瑛. 支气管扩张症的中医证候特征与中医药治疗研究进展. 中国疗养医学. 2023(02): 139-143 .
    4. 刘中友,郑晓娜. 千金清肺汤联合西药治疗痰热型支气管扩张的临床疗效及对外周血Th17/Treg失衡及相关因子表达的影响. 安徽医药. 2023(04): 835-839 .
    5. 李静,李映,冯品画. 万病回春清肺汤治疗支气管扩张并感染的临床观察及对肺功能的影响. 中国医学创新. 2023(09): 41-45 .
    6. 周同鑫,石静娟,裴昶,曹振华,殷智,钱丽. “支炎一号”方治疗成人痰热壅肺型支气管扩张临床疗效分析. 中外医疗. 2022(02): 103-106 .
    7. 车启富,何丽杰. 桔芩汤联合支气管镜肺泡灌洗术治疗支气管扩张患者的临床效果. 国际医药卫生导报. 2022(06): 858-862 .
    8. 胡文海,叶欣,汤国敏. 桔芩汤治疗支气管扩张患者对临床证候、肺通气功能的影响. 中医临床研究. 2022(02): 44-47 .
    9. 徐瑜俊. 云南白药胶囊与酚妥拉明联合用药方案治疗支气管扩张咯血的临床效果. 现代医学与健康研究电子杂志. 2022(09): 92-94 .
    10. 钟云青,胡春明,黄丽敏. 支气管扩张症急性加重痰热蕴肺证的中医治疗进展. 医学综述. 2022(15): 3057-3061 .
    11. 周亮亮,任宏伟,曹国芸,李梦云,李芳,刘宁,王玉彬. 清肺化痰解毒汤联合头孢哌酮/舒巴坦治疗支气管扩张症伴感染(痰热壅肺证)的临床研究. 中国中医急症. 2022(11): 1941-1944 .
    12. 孙锦贤,余静珠,屠春林,胡建荣,朱丽萍. 加味桔芩汤对支气管扩张痰热壅肺证抑郁焦虑、生命质量、炎症标记物及肺功能的疗效观察. 吉林中医药. 2022(12): 1418-1421 .
    13. 谭道富,谭艳华,田朝晖,向建军. 山药化痰汤治疗对气阴两虚痰热壅肺型老年重症肺炎患者中医症状积分和肺功能的影响. 四川中医. 2022(11): 99-102 .
    14. 谢文,黄青松. 中医药治疗支气管扩张症的药理机制研究进展. 中医药导报. 2021(08): 123-127 .
    15. 田艳艳,严廷巍,李景莉,马兰萍. 清肺消痈方联合盐酸氨溴索治疗支气管扩张症的效果及对患者MCP-1、MMP-9的影响. 四川中医. 2021(12): 84-87 .
    16. 赵芳,刘振国,常瑛,葛莉,李芳. 肺热清颗粒联用糖皮质激素对小儿支气管哮喘氧化/抗氧化失衡的影响. 湖南师范大学学报(医学版). 2021(06): 171-174 .
    17. 聂光荣. 百合固金汤联合复方穿心莲治疗阴虚肺热型支气管扩张的临床疗效. 临床合理用药杂志. 2020(36): 131-133 .

    Other cited types(4)

Catalog

    Article views (117) PDF downloads (11) Cited by(21)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return